表紙
市場調査レポート

胸水:世界の治験レビュー

Pleural Effusion Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 322179
出版日 ページ情報 英文 69 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
胸水:世界の治験レビュー Pleural Effusion Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 69 Pages
概要

当レポートでは、胸水の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 胸水
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:呼吸器系疾患の治験における胸水の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:呼吸器系疾患の治験における胸水の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

胸水治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • F. Hoffmann-La Roche Ltd.
    • Eli Lilly and Company
    • Sanofi
    • E. Merck KG
    • CytRx Corporation
    • Cumberland Pharmaceuticals, Inc.
    • CanBas Co., Ltd.
    • C. H. Boehringer Sohn AG & Co. KG
    • Advantagene, Inc.
    • ABNOBA Korea
  • 代表的な研究機関・病院の治験の概要
    • National Cancer Institute
    • University of Texas M. D. Anderson Cancer Center
    • University of Oxford
    • Memorial Sloan Kettering Cancer Center
    • Huazhong University of Science & Technology
    • University of California, Davis
    • University of Pennsylvania
    • University of Washington
    • North Bristol NHS Trust

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2505CTIDB

GlobalData's clinical trial report, "Pleural Effusion Global Clinical Trials Review, H2, 2014" provides data on the Pleural Effusion clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pleural Effusion. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pleural Effusion. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Pleural Effusion
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Pleural Effusion to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pleural Effusion to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Pleural Effusion
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Pleural Effusion Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • CytRx Corporation
      • Clinical Trial Overview of CytRx Corporation
      • Cumberland Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cumberland Pharmaceuticals, Inc.
      • CanBas Co., Ltd.
      • Clinical Trial Overview of CanBas Co., Ltd.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Advantagene, Inc.
      • Clinical Trial Overview of Advantagene, Inc.
      • ABNOBA Korea
      • Clinical Trial Overview of ABNOBA Korea
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Huazhong University of Science & Technology
      • Clinical Trial Overview of Huazhong University of Science & Technology
      • University of California, Davis
      • Clinical Trial Overview of University of California, Davis
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • North Bristol NHS Trust
      • Clinical Trial Overview of North Bristol NHS Trust
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Pleural Effusion Therapeutics, Global, Clinical Trials by Region, 2014*
  • Pleural Effusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Pleural Effusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Pleural Effusion to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Pleural Effusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Pleural Effusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Pleural Effusion to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Pleural Effusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Pleural Effusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Pleural Effusion Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Pleural Effusion Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Pleural Effusion Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Pleural Effusion Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Pleural Effusion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by CytRx Corporation, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Cumberland Pharmaceuticals, Inc., 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by CanBas Co., Ltd., 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Advantagene, Inc., 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by ABNOBA Korea, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Huazhong University of Science & Technology, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
  • Pleural Effusion Therapeutics Clinical Trials Market, Global, Clinical Trials by North Bristol NHS Trust, 2014*

List of Figures

  • Pleural Effusion Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Pleural Effusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Pleural Effusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Pleural Effusion Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Pleural Effusion to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Pleural Effusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Pleural Effusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Pleural Effusion to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Pleural Effusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Pleural Effusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Pleural Effusion Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Pleural Effusion Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Pleural Effusion Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Pleural Effusion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Pleural Effusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top